GLUE
Monte Rosa Therapeutics Inc
11.80$
+0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 55.5% | -18.4% | |
| – | – | – | – | – | 10.7% | 6.8% | |
| – | – | – | – | – | 24.0% | 15.3% | |
| – | – | – | – | – | 120.9% | -7.4% | |
| – | – | – | – | – | 5.3% | 3.8% | |
| – | – | – | – | – | -58.8% | -82.3% | |
| – | – | – | – | – | -0.8% | -0.3% | |
| – | – | – | – | – | 130.8% | 24.5% | |
| – | – | – | – | – | 127.5% | -76.2% | |
| – | – | – | – | – | 50.3% | -22.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.